PKD FOUNDATION for PKD FOUNDATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
FY 2011 Defense Appropriations bill: Followed up on requests in the House for establishing a polycystic kidney disease (PKD) research program funded at $5 million in the DoD Congressionally Directed Medical Research Program; FY 2011 Defense Appropriations bill: Filed and followed up on requests in the Senate for keeping PKD listed as a disease eligible to compete for funding under the DoD Peer Reviewed Medical Research Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
| DAN E LARSON | — |
Health Issues HCR
Met with Rep. Beccera's office to discuss potential of Gene Patent legislation. There is no bill yet.; Scheduled meetings and began discussions with House Energy and Commerce committee staff and other personal offices regarding polycystic kidney disease and the Food and Drug Administration's Critical Path Institute
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
Medicare/Medicaid MMM
H.R. 1458/S. 565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act: Met with Ways and Means committee staff; advocacy to increase co-sponsorship of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
| DAN E LARSON | — |
Budget/Appropriations BUD
FY 2011 Labor-HHS-Education Appropriations bill: Followed up on requests for report language referencing polycystic kidney disease (PKD); Advocate for overall increase in funding for the National Institues of Health (NIH)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
| DAN E LARSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.